95716-74-8 Usage
General Description
17β-hydroxypregna-4,9(11)-dien-3-one-7α,21-dicarboxylic acid γ-lactone is a chemical compound and a synthetic steroid derivative. It is a lactone form of 17β-hydroxypregna-4,9(11)-dien-3-one-7α,21-dicarboxylic acid, which is a derivative of progesterone. 17β-hydroxypregna-4,9(11)-dien-3-one-7α,21-dicarboxylic acid γ-lactone has potential pharmaceutical applications and is often used in research and development of new drugs. It has been studied for its potential anti-inflammatory, antitumor, and immunosuppressive effects. Additionally, it has been investigated for its potential use in hormone replacement therapy and as a treatment for various medical conditions. Overall, 17β-hydroxypregna-4,9(11)-dien-3-one-7α,21-dicarboxylic acid γ-lactone is a compound of interest in the pharmaceutical and medical fields due to its diverse potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 95716-74-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,5,7,1 and 6 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 95716-74:
(7*9)+(6*5)+(5*7)+(4*1)+(3*6)+(2*7)+(1*4)=168
168 % 10 = 8
So 95716-74-8 is a valid CAS Registry Number.
95716-74-8Relevant articles and documents
A new approach to the furan degradation problem involving ozonolysis of the trans-enedione and its use in a cost-effective synthesis of eplerenone
Pearlman, Bruce A.,Padilla, Amphlett G.,Hach, John T.,Havens, Jeffrey L.,Pillai, Muniraj D.
, p. 2111 - 2113 (2006)
Whereas ozonization of furan 3a affords little or no carboxylic acid 5, ozonization of the corresponding trans-enedione 6 afforded carboxylic acid 5 in 82.4% yield (cryst., overall from furan, 100 g scale; after workup with dimethyl sulfide, followed by mildly basic hydrogen peroxide). This new approach to furan degradation is showcased in a cost-effective synthesis of eplerenone, an important new medicine for cardiovascular indications.
